58 related articles for article (PubMed ID: 38461087)
21. Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives.
Nikas IP; Themistocleous SC; Paschou SA; Tsamis KI; Ryu HS
Cells; 2019 Dec; 9(1):. PubMed ID: 31861708
[TBL] [Abstract][Full Text] [Related]
22. Regulation of chemoresistance via alternative messenger RNA splicing.
Eblen ST
Biochem Pharmacol; 2012 Apr; 83(8):1063-72. PubMed ID: 22248731
[TBL] [Abstract][Full Text] [Related]
23. Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis.
Duggan WP; O'Connell E; Prehn JHM; Burke JP
Mol Cell Biochem; 2022 Oct; 477(10):2451-2467. PubMed ID: 35583632
[TBL] [Abstract][Full Text] [Related]
24. "Nought may endure but mutability": spliceosome dynamics and the regulation of splicing.
Smith DJ; Query CC; Konarska MM
Mol Cell; 2008 Jun; 30(6):657-66. PubMed ID: 18570869
[TBL] [Abstract][Full Text] [Related]
25. Non-canonical functions of spliceosome components in cancer progression.
Ivanova OM; Anufrieva KS; Kazakova AN; Malyants IK; Shnaider PV; Lukina MM; Shender VO
Cell Death Dis; 2023 Feb; 14(2):77. PubMed ID: 36732501
[TBL] [Abstract][Full Text] [Related]
26. Alternative splicing in Alzheimer's disease.
Biamonti G; Amato A; Belloni E; Di Matteo A; Infantino L; Pradella D; Ghigna C
Aging Clin Exp Res; 2021 Apr; 33(4):747-758. PubMed ID: 31583531
[TBL] [Abstract][Full Text] [Related]
27. Pre-mRNA splicing-associated diseases and therapies.
Love SL; Emerson JD; Koide K; Hoskins AA
RNA Biol; 2023 Jan; 20(1):525-538. PubMed ID: 37528617
[TBL] [Abstract][Full Text] [Related]
28. Variant snRNPs: New players within the spliceosome system.
Vazquez-Arango P; O'Reilly D
RNA Biol; 2018 Jan; 15(1):17-25. PubMed ID: 28876172
[TBL] [Abstract][Full Text] [Related]
29. The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.
Daguenet E; Dujardin G; Valcárcel J
EMBO Rep; 2015 Dec; 16(12):1640-55. PubMed ID: 26566663
[TBL] [Abstract][Full Text] [Related]
30. Dysregulation of splicing variants and spliceosome components in breast cancer.
Gahete MD; Herman-Sanchez N; Fuentes-Fayos AC; Lopez-Canovas JL; Luque RM
Endocr Relat Cancer; 2022 Sep; 29(9):R123-R142. PubMed ID: 35728261
[TBL] [Abstract][Full Text] [Related]
31. Role of computational and structural biology in the development of small-molecule modulators of the spliceosome.
Rozza R; Janoš P; Spinello A; Magistrato A
Expert Opin Drug Discov; 2022 Oct; 17(10):1095-1109. PubMed ID: 35983696
[TBL] [Abstract][Full Text] [Related]
32. Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing.
Garcia-Blanco MA
J Clin Invest; 2003 Aug; 112(4):474-80. PubMed ID: 12925685
[TBL] [Abstract][Full Text] [Related]
33. Aberrant RNA splicing and therapeutic opportunities in cancers.
Yamauchi H; Nishimura K; Yoshimi A
Cancer Sci; 2022 Feb; 113(2):373-381. PubMed ID: 34812550
[TBL] [Abstract][Full Text] [Related]
34. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
Urbanski LM; Leclair N; Anczuków O
Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
[TBL] [Abstract][Full Text] [Related]
35. How Is Precursor Messenger RNA Spliced by the Spliceosome?
Wan R; Bai R; Zhan X; Shi Y
Annu Rev Biochem; 2020 Jun; 89():333-358. PubMed ID: 31815536
[TBL] [Abstract][Full Text] [Related]
36. The spliceosome and its metal ions.
Butcher SE
Met Ions Life Sci; 2011; 9():235-51. PubMed ID: 22010274
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic targeting of splicing in cancer.
Lee SC; Abdel-Wahab O
Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
[TBL] [Abstract][Full Text] [Related]
38. Splicing diversity revealed by reduced spliceosomes in C. merolae and other organisms.
Hudson AJ; Stark MR; Fast NM; Russell AG; Rader SD
RNA Biol; 2015; 12(11):1-8. PubMed ID: 26400738
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic insights into precursor messenger RNA splicing by the spliceosome.
Shi Y
Nat Rev Mol Cell Biol; 2017 Nov; 18(11):655-670. PubMed ID: 28951565
[TBL] [Abstract][Full Text] [Related]
40. Spliceosomal factor mutations and mis-splicing in MDS.
Hershberger CE; Daniels NJ; Padgett RA
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101199. PubMed ID: 33038983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
